Advances in clinical chemistry. Volume 108 /
Advances in Clinical Chemistry, Volume 108, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to th...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Amsterdam :
Academic Press,
2022.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Chapter Three: Testosterone analysis in prostate cancer patients
- 1. Introduction
- 2. Gonadal testosterone regulation
- 3. Evolution of androgen deprivation therapy
- 3.1. Surgical intervention and estrogen administration
- 3.2. LHRH agonists and antagonists
- 3.3. AR inhibitors
- 3.4. CYP17A1 inhibition
- 3.5. Bipolar androgen therapy
- 4. Testosterone analysis
- 4.1. Early testosterone analysis
- 4.2. Contemporary testosterone analysis
- 4.2.1. Automated IA
- 4.2.2. Mass spectrometry-based assays
- 5. Automated IA vs LC-MS/MS assays
- 6. Potential clinical utility of ultra-sensitive testosterone assays
- 7. Conclusion
- References
- Chapter Four: Extracellular vesicles in respiratory disease
- 1. Introduction
- 1.1. Extracellular vesicles
- 1.2. Types of EVs
- 1.3. General functions of EVs
- 2. Experimental techniques for EV research
- 2.1. Methods for EV isolation
- 2.1.1. Differential centrifugation
- 2.1.2. Density gradient centrifugation
- 2.1.3. Size exclusion chromatography
- 2.1.4. Commercial kits for polymer precipitation
- 2.1.5. Precipitation with chemicals
- 2.1.6. Immunoprecipitation
- 2.1.7. Ultrafiltration
- 2.1.8. Microfluidic technologies
- 2.2. Methods for EV characterization
- 2.2.1. Dynamic light scattering
- 2.2.2. Nanoparticle tracking analysis
- 2.2.3. Nanoscale flow cytometry
- 2.2.4. Transmission electron microscopy
- 3. EVs in the respiratory system
- 3.1. EVs from BALF
- 3.2. Biological significance of EVs in common respiratory diseases
- 3.2.1. Acute lung injury and acute respiratory distress syndrome
- 3.2.2. Chronic obstructive pulmonary disease
- 3.2.3. Pulmonary arterial hypertension
- 3.2.4. Idiopathic pulmonary fibrosis
- 3.2.5. Asthma
- 3.3. Clinical applications of respiratory EVs
- 3.3.1. Respiratory EV-miRNAs as diagnostic markers.